Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.400
-0.010 (-0.71%)
At close: Dec 5, 2025, 4:00 PM EST
1.370
-0.030 (-2.15%)
After-hours: Dec 5, 2025, 6:15 PM EST
Vivani Medical Employees
Vivani Medical had 37 employees as of December 31, 2024. The number of employees decreased by 7 or -15.91% compared to the previous year.
Employees
37
Change (1Y)
-7
Growth (1Y)
-15.91%
Revenue / Employee
n/a
Profits / Employee
-$703,405
Market Cap
102.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37 | -7 | -15.91% |
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VANI News
- 22 days ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 2 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 2 months ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 - GlobeNewsWire
- 2 months ago - Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewsWire
- 3 months ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire
- 3 months ago - Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 - GlobeNewsWire